AIMLogo.jpg
Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities
May 31, 2017 11:38 ET | Hemispherx Biopharma, Inc.
PHILADELPHIA, May 31, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the “Company") announced today that it continues to build its manufacturing and scientific...
AIMLogo.jpg
Hemispherx Biopharma Bolsters Manufacturing and Scientific Capabilities Through Key Consulting and Management Appointments
July 19, 2016 08:35 ET | Hemispherx Biopharma, Inc.
Promotes Carol Smith, Ph.D., to Manager of Quality as Part of Manufacturing Optimization Retains Step Change Pharma as Advisor to Strengthen Manufacturing and Technical Infrastructure Retains...